Canadian microbiologists announced the launch of the CAN-R website at a conference held last month in Halifax, Nova Scotia.
The launch of CAN-R was announced March 15 at the 2007 joint conference of the Association of Medical Microbiology and Infectious Disease (AMMI) Canada and the Canadian Association of Clinical Microbiology and Infectious Diseases (CACMID) held in Halifax.
CAN-R is an initiative developed by the Canadian Antibiotic Resistance Alliance (CARA) to respond to the rising prevalence of antibiotic-resistant microorganisms in Canadian hospitals and communities. The website will provide information on the rise of antibiotic resistance in Canada and solutions to reduce the threat of antibiotic resistance organisms to our healthcare system.
Study findings from a number of antibiotic-resistance surveillance programs will be provided as resources and educational aids to Canadian healthcare providers and researchers. Information is provided on the prevalence of "superbugs" in Canadian hospitals, surveillance initiatives, antimicrobial usage, clinical guidelines for treating infection, as well as current research on antibiotic-resistant bacteria and new antimicrobial agents.
The term superbug is generally applied by the media to antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and extended-spectrum beta-lactamases (ESBLs).
Related content:
Methicillin-Resistant Staph: Superbug Infections
Staph and Methicillin Resistance
Source:
